Milton L Pressler
age ~71
from Carmel, IN
- Also known as:
-
- Milton Dr Pressler
Milton Pressler Phones & Addresses
- Carmel, IN
- Indianapolis, IN
- 4375 Lakeside Ct, Ann Arbor, MI 48108 • 734 222-5303
- 7194 Partridge Way, Saline, MI 48176 • 734 944-9200
- 2002 Waters Edge Dr #56, Westlake, OH 44145 • 734 944-9200
- Goshen, IN
- Morris Plains, NJ
- 7194 Partridge Way, Saline, MI 48176
Work
-
Position:Homemaker
Education
-
School / High School:Northwestern Center Feinberg School of Medicine1976
Languages
English
Awards
Healthgrades Honor Roll
Ranks
-
Certificate:Cardiovascular Disease, 1981
Specialities
Cardiology
Medicine Doctors
Dr. Milton L Pressler, Ann Arbor MI - MD (Doctor of Medicine)
view sourceSpecialties:
Cardiology
Address:
4375 Lakeside Ct, Ann Arbor, MI 48108
Certifications:
Cardiovascular Disease, 1981
Internal Medicine, 1979
Internal Medicine, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1976
Medical School
Iu Health University
Graduated: 1976
Northwestern Center Feinberg School of Medicine
Graduated: 1976
Medical School
Iu Health University
Graduated: 1976
Milton Lethan Pressler
view sourceSpecialties:
Internal Medicine
Cardiovascular Disease
Cardiology
Cardiovascular Disease
Cardiology
Education:
Northwestern University (1976)
Name / Title
Company / Classification
Phones & Addresses
Milton Pressler MD
Internist
Internist
4375 Lakeside Ct, Ann Arbor, MI 48108
GREENLAND NURSERY, INC
Westlake, OH
PRESSLER - WEISSINGER COMPANY
Rocky River, OH
BAY BEAUTY SHOPPE, INC
Bay Village, OH
CITY AND SUBURBAN INSURANCE AGENCY, INCORPORATED
Fairview Park, OH
FAIRVIEW PARK INVESTMENT CORPORATION
Fairview Park, OH
Us Patents
-
Method For Treating Postoperative Ileus
view source -
US Patent:6645959, Nov 11, 2003
-
Filed:Apr 19, 2002
-
Appl. No.:10/111274
-
Inventors:Rebecca Guggemos Bakker-Arkema - Ann Arbor MI
Milton Lethan Pressler - Saline MI -
Assignee:Warner-Lambert Company - Morris Plains NJ
-
International Classification:A61K 3155
-
US Classification:514215, 514200, 514481, 514471
-
Abstract:This invention is a method for preventing or treating postoperative ileus comprising administering a vasopressin antagonist such as a compound of Formula (1), where R , R , and R include hydrogen, halo, alkyl, and alkoxy; R and R are hydrogen or alkyl; R is hydrogen, phenyl, or substituted phenyl, and pharmaceutically acceptable salts thereof.
-
Treatment Of Pulmonary Hypertension
view source -
US Patent:6740648, May 25, 2004
-
Filed:Oct 3, 2001
-
Appl. No.:09/970211
-
Inventors:Maha Ghazzi - Ann Arbor MI
Milton Lethan Pressler - Saline MI -
Assignee:Warner-Lambert Company - Morris Plains NJ
-
International Classification:A61K 3155
-
US Classification:514217
-
Abstract:Disclosed is a method for treating pulmonary hypertension using a vasopressin antagonist.
-
Treatment Of Congestive Heart Failure
view source -
US Patent:7192951, Mar 20, 2007
-
Filed:Jun 16, 2005
-
Appl. No.:11/154909
-
Inventors:Rebecca Guggemos Bakker-Arkema - Ann Arbor MI, US
Milton Lethan Pressler - Saline MI, US -
Assignee:Astellas Pharma Inc.
-
International Classification:A61K 31/55
A61K 31/34 -
US Classification:514215, 514471
-
Abstract:Combinations of diuretics and vasopressin antagonists are useful to slow and reverse the symptoms and process of congestive heart failure, to increase the excretion of water in the urine, and to decrease the excretion of sodium and potassium ions in urine. Preferred vasopressin antagonists have the formula.
-
Method For Treating Chronic Obstructive Pulmonary Disease
view source -
US Patent:20020115661, Aug 22, 2002
-
Filed:Sep 7, 2001
-
Appl. No.:09/949204
-
Inventors:Laurence Keller - Ann Arbor MI, US
Milton Pressler - Saline MI, US -
International Classification:A61K031/5415
-
US Classification:514/226500
-
Abstract:Chronic obstructive pulmonary disease is treated with a selective ETreceptor antagonist such as 4-(7-ethyl-1,3-benxodioxol-5-yl)-2-[2-trifluoromethyl) phenyl]-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide or a pharmaceutically acceptable salt thereof.
-
Treatment Of Congestive Heart Failure
view source -
US Patent:20030008860, Jan 9, 2003
-
Filed:May 9, 2002
-
Appl. No.:10/129892
-
Inventors:Rebecca Bakker-Arkema - Ann Arbor MI, US
Milton Pressler - Saline MI, US -
International Classification:A61K031/55
A61K031/34 -
US Classification:514/215000, 514/471000
-
Abstract:Combinations of diuretics and vasopressin antagonists are useful to slow and reverse the symptoms and process of congestive heart failure, to increase the excretion of water in the urine, and to decrease the excretion of sodium and potassium ions in urine. Preferred vasopressin antagonists have the formula (I) wherein R and Rare hydrogen or lower alkyl; R, R, and Rare hydrogen, halo, alkyl, alkoxy, and amino; and Ris hydrogen or phenyl, and a pharmaceutically acceptable salt thereof
-
Ace Inhibitor-Vasopressin Antagonist Combinations
view source -
US Patent:20030103983, Jun 5, 2003
-
Filed:May 9, 2002
-
Appl. No.:10/130168
-
Inventors:Milton Pressler - Saline MI, US
-
International Classification:A61K039/395
-
US Classification:424/176100
-
Abstract:Combinations of ACE inhibitors and vasopressin antagonists are useful to slow and reverse the process of ventricular dilation, and CHF in mammals.
-
Treatment Of Congestive Heart Failure
view source -
US Patent:20040176354, Sep 9, 2004
-
Filed:Mar 12, 2004
-
Appl. No.:10/799415
-
Inventors:Rebecca Bakker-Arkema - Ann Arbor MI, US
Milton Pressler - Saline MI, US -
International Classification:A61K031/55
-
US Classification:514/215000
-
Abstract:Combinations of diuretics and vasopressin antagonists are useful to slow and reverse the symptoms and process of congestive heart failure, to increase the excretion of water in the urine, and to decrease the excretion of sodium and potassium ions in urine. Preferred vasopressin antagonists have the formula wherein R and Rare hydrogen or lower alkyl; R, R, and Rare hydrogen, halo, alkyl, alkoxy, and amino; and Ris hydrogen or phenyl, and a pharmaceutically acceptable salt thereof.
-
Coronary Artery Disease Treatment
view source -
US Patent:20050191278, Sep 1, 2005
-
Filed:Apr 12, 2005
-
Appl. No.:11/104126
-
Inventors:Milton Pressler - Saline MI, US
Donald Black - Princeton NJ, US
Paul Fischer - North Potomac MD, US
Henrik Rasmussen - Arnold MD, US
Margaret Samyn - Gainesville FL, US
Grant Yonehiro - San Mateo CA, US -
Assignee:GenVec, Inc. - Gaithersburg MD
Warner-Lambert Company - Morris Plains NJ -
International Classification:A61K048/00
A61M031/00 -
US Classification:424093200, 604500000
-
Abstract:The invention provides a method of treating coronary artery disease in a human patient comprising directly injecting into an ischemic cardiac muscle, via multiple injections to different points of the cardiac muscle, a dose of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding an angiogenic peptide operably linked to a promoter, whereby the coronary artery disease is treated.
Youtube
Get Report for Milton L Pressler from Carmel, IN, age ~71